PubMed:12002902
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-121 | Sentence | denotes | Screening for mutations in exons encoding the ligand-binding domain of the LDL receptor gene using PCR-CFLP and PCR-SSCP. |
| TextSentencer_T2 | 122-210 | Sentence | denotes | Primary hypercholesterolemia includes both monogenic disorders and polygenic conditions. |
| TextSentencer_T3 | 211-343 | Sentence | denotes | Two well defined monogenic disorders are familial hypercholesterolemia (FH) and familial defective apolipoprotein (apo) B-100 (FDB). |
| TextSentencer_T4 | 344-413 | Sentence | denotes | Both disorders convey high risk of premature coronary artery disease. |
| TextSentencer_T5 | 414-499 | Sentence | denotes | FH and FDB are caused by mutations in LDL receptor and apo B-100 genes, respectively. |
| TextSentencer_T6 | 500-611 | Sentence | denotes | In the present study, mutations in both genes in Thai subjects with primary hypercholesterolemia were screened. |
| TextSentencer_T7 | 612-670 | Sentence | denotes | For apo B-100 gene, a common mutation R3500Q was screened. |
| TextSentencer_T8 | 671-727 | Sentence | denotes | This mutation was not observed in the patients (n = 45). |
| TextSentencer_T9 | 728-823 | Sentence | denotes | For LDL receptor gene, mutations in the exons encoding the ligand-binding domain were screened. |
| TextSentencer_T10 | 824-941 | Sentence | denotes | By PCR-CFLP analysis, 18 abnormal CFLP patterns in exon 4, the hot spot for mutations, were found in patients (n=45). |
| TextSentencer_T11 | 942-1085 | Sentence | denotes | One of the DNA samples with abnormal CFLP patterns was previously identified and reported as a possible disease-causing mutation, namely D151Y. |
| TextSentencer_T12 | 1086-1144 | Sentence | denotes | For the other exons, the screening technique was PCR-SSCP. |
| TextSentencer_T13 | 1145-1282 | Sentence | denotes | Abnormal SSCP patterns in DNA samples from patients (n=20) were found as follows, two in exon 3, one in exon 5 and another one in exon 6. |
| TextSentencer_T14 | 1283-1386 | Sentence | denotes | Further characterization by DNA sequencing and family studies for these abnormal patterns are underway. |
| T1 | 0-121 | Sentence | denotes | Screening for mutations in exons encoding the ligand-binding domain of the LDL receptor gene using PCR-CFLP and PCR-SSCP. |
| T2 | 122-210 | Sentence | denotes | Primary hypercholesterolemia includes both monogenic disorders and polygenic conditions. |
| T3 | 211-343 | Sentence | denotes | Two well defined monogenic disorders are familial hypercholesterolemia (FH) and familial defective apolipoprotein (apo) B-100 (FDB). |
| T4 | 344-413 | Sentence | denotes | Both disorders convey high risk of premature coronary artery disease. |
| T5 | 414-499 | Sentence | denotes | FH and FDB are caused by mutations in LDL receptor and apo B-100 genes, respectively. |
| T6 | 500-611 | Sentence | denotes | In the present study, mutations in both genes in Thai subjects with primary hypercholesterolemia were screened. |
| T7 | 612-670 | Sentence | denotes | For apo B-100 gene, a common mutation R3500Q was screened. |
| T8 | 671-727 | Sentence | denotes | This mutation was not observed in the patients (n = 45). |
| T9 | 728-823 | Sentence | denotes | For LDL receptor gene, mutations in the exons encoding the ligand-binding domain were screened. |
| T10 | 824-941 | Sentence | denotes | By PCR-CFLP analysis, 18 abnormal CFLP patterns in exon 4, the hot spot for mutations, were found in patients (n=45). |
| T11 | 942-1085 | Sentence | denotes | One of the DNA samples with abnormal CFLP patterns was previously identified and reported as a possible disease-causing mutation, namely D151Y. |
| T12 | 1086-1144 | Sentence | denotes | For the other exons, the screening technique was PCR-SSCP. |
| T13 | 1145-1282 | Sentence | denotes | Abnormal SSCP patterns in DNA samples from patients (n=20) were found as follows, two in exon 3, one in exon 5 and another one in exon 6. |
| T14 | 1283-1386 | Sentence | denotes | Further characterization by DNA sequencing and family studies for these abnormal patterns are underway. |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 130-150 | HP_0003124 | denotes | hypercholesterolemia |
| T2 | 261-281 | HP_0003124 | denotes | hypercholesterolemia |
| T3 | 379-412 | HP_0005181 | denotes | premature coronary artery disease |
| T4 | 389-412 | HP_0001677 | denotes | coronary artery disease |
| T5 | 576-596 | HP_0003124 | denotes | hypercholesterolemia |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 12002902-2#115#125#gene338 | 326-336 | gene338 | denotes | apo) B-100 |
| 12002902-2#127#130#gene338 | 338-341 | gene338 | denotes | FDB |
| 12002902-2#41#70#diseaseC0745103 | 252-281 | diseaseC0745103 | denotes | familial hypercholesterolemia |
| 12002902-2#41#70#diseaseC0020445 | 252-281 | diseaseC0020445 | denotes | familial hypercholesterolemia |
| 12002902-2#72#74#diseaseC0745103 | 283-285 | diseaseC0745103 | denotes | FH |
| 12002902-2#72#74#diseaseC0020445 | 283-285 | diseaseC0020445 | denotes | FH |
| 12002902-2#41#70#diseaseC0745103 | 252-281 | diseaseC0745103 | denotes | familial hypercholesterolemia |
| 12002902-2#41#70#diseaseC0020445 | 252-281 | diseaseC0020445 | denotes | familial hypercholesterolemia |
| 12002902-2#72#74#diseaseC0745103 | 283-285 | diseaseC0745103 | denotes | FH |
| 12002902-2#72#74#diseaseC0020445 | 283-285 | diseaseC0020445 | denotes | FH |
| 115#125#gene33841#70#diseaseC0745103 | 12002902-2#115#125#gene338 | 12002902-2#41#70#diseaseC0745103 | associated_with | apo) B-100,familial hypercholesterolemia |
| 115#125#gene33841#70#diseaseC0020445 | 12002902-2#115#125#gene338 | 12002902-2#41#70#diseaseC0020445 | associated_with | apo) B-100,familial hypercholesterolemia |
| 115#125#gene33872#74#diseaseC0745103 | 12002902-2#115#125#gene338 | 12002902-2#72#74#diseaseC0745103 | associated_with | apo) B-100,FH |
| 115#125#gene33872#74#diseaseC0020445 | 12002902-2#115#125#gene338 | 12002902-2#72#74#diseaseC0020445 | associated_with | apo) B-100,FH |
| 115#125#gene33841#70#diseaseC0745103 | 12002902-2#115#125#gene338 | 12002902-2#41#70#diseaseC0745103 | associated_with | apo) B-100,familial hypercholesterolemia |
| 115#125#gene33841#70#diseaseC0020445 | 12002902-2#115#125#gene338 | 12002902-2#41#70#diseaseC0020445 | associated_with | apo) B-100,familial hypercholesterolemia |
| 115#125#gene33872#74#diseaseC0745103 | 12002902-2#115#125#gene338 | 12002902-2#72#74#diseaseC0745103 | associated_with | apo) B-100,FH |
| 115#125#gene33872#74#diseaseC0020445 | 12002902-2#115#125#gene338 | 12002902-2#72#74#diseaseC0020445 | associated_with | apo) B-100,FH |
| 127#130#gene33841#70#diseaseC0745103 | 12002902-2#127#130#gene338 | 12002902-2#41#70#diseaseC0745103 | associated_with | FDB,familial hypercholesterolemia |
| 127#130#gene33841#70#diseaseC0020445 | 12002902-2#127#130#gene338 | 12002902-2#41#70#diseaseC0020445 | associated_with | FDB,familial hypercholesterolemia |
| 127#130#gene33872#74#diseaseC0745103 | 12002902-2#127#130#gene338 | 12002902-2#72#74#diseaseC0745103 | associated_with | FDB,FH |
| 127#130#gene33872#74#diseaseC0020445 | 12002902-2#127#130#gene338 | 12002902-2#72#74#diseaseC0020445 | associated_with | FDB,FH |
| 127#130#gene33841#70#diseaseC0745103 | 12002902-2#127#130#gene338 | 12002902-2#41#70#diseaseC0745103 | associated_with | FDB,familial hypercholesterolemia |
| 127#130#gene33841#70#diseaseC0020445 | 12002902-2#127#130#gene338 | 12002902-2#41#70#diseaseC0020445 | associated_with | FDB,familial hypercholesterolemia |
| 127#130#gene33872#74#diseaseC0745103 | 12002902-2#127#130#gene338 | 12002902-2#72#74#diseaseC0745103 | associated_with | FDB,FH |
| 127#130#gene33872#74#diseaseC0020445 | 12002902-2#127#130#gene338 | 12002902-2#72#74#diseaseC0020445 | associated_with | FDB,FH |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1415 | 326-336 | gene:338 | denotes | apo) B-100 |
| T1416 | 252-281 | disease:C0745103 | denotes | familial hypercholesterolemia |
| T1417 | 283-285 | disease:C0745103 | denotes | FH |
| T1418 | 338-341 | gene:338 | denotes | FDB |
| R1 | T1415 | T1416 | associated_with | apo) B-100,familial hypercholesterolemia |
| R2 | T1415 | T1416 | associated_with | apo) B-100,familial hypercholesterolemia |
| R3 | T1415 | T1417 | associated_with | apo) B-100,FH |
| R4 | T1415 | T1417 | associated_with | apo) B-100,FH |
| R5 | T1418 | T1416 | associated_with | FDB,familial hypercholesterolemia |
| R6 | T1418 | T1416 | associated_with | FDB,familial hypercholesterolemia |
| R7 | T1418 | T1417 | associated_with | FDB,FH |
| R8 | T1418 | T1417 | associated_with | FDB,FH |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 389-404 | http://purl.obolibrary.org/obo/UBERON_0001621 | denotes | coronary artery |
| PD-UBERON-AE-B_T2 | 398-404 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | artery |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 389-404 | http://purl.obolibrary.org/obo/UBERON_0001621 | denotes | coronary artery |
| PD-UBERON-AE-B_T2 | 398-404 | http://purl.obolibrary.org/obo/UBERON_0001637 | denotes | artery |
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 326-336 | gene:338 | denotes | apo) B-100 |
| T1 | 252-281 | disease:C0020445 | denotes | familial hypercholesterolemia |
| T2 | 326-336 | gene:338 | denotes | apo) B-100 |
| T3 | 283-285 | disease:C0020445 | denotes | FH |
| T4 | 338-341 | gene:338 | denotes | FDB |
| T5 | 252-281 | disease:C0020445 | denotes | familial hypercholesterolemia |
| T6 | 338-341 | gene:338 | denotes | FDB |
| T7 | 283-285 | disease:C0020445 | denotes | FH |
| R1 | T0 | T1 | associated_with | apo) B-100,familial hypercholesterolemia |
| R2 | T2 | T3 | associated_with | apo) B-100,FH |
| R3 | T4 | T5 | associated_with | FDB,familial hypercholesterolemia |
| R4 | T6 | T7 | associated_with | FDB,FH |